Skip to main content
Erschienen in: Tumor Biology 2/2014

01.02.2014 | Research Article

An updated meta-analysis of the association between GSTM1 polymorphism and colorectal cancer in Asians

verfasst von: Xiang Cai, Lie Yang, Haining Chen, Cun Wang

Erschienen in: Tumor Biology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Glutathione S-transferases (GSTs) are a large family of phase II detoxification enzymes that are expressed in many tissues and play critical roles in protecting hosts against cancer. The association of glutathione S-transferase M1 (GSTM1) polymorphism with susceptibility to colorectal cancer in Asians has not been well established. We performed a meta-analysis to quantitatively assess the association between GSTM1 polymorphism and colorectal cancer in Asians. We systematically searched the PubMed and Embase databases to identify the eligible studies. Finally, 17 eligible studies with 5,907 cases and 9,726 controls were included into the meta-analysis. The pooled odds ratio (OR) with its 95 % confidence intervals (95 %CI) was used to assess the association. The meta-analysis of those included studies suggests that GSTM1 null genotype was significantly associated with colorectal cancer risk in Asians (OR = 1.14, 95 %CI = 1.013–1.29, P = 0.03). The cumulative meta-analyses showed a trend of an obvious association between the GSTM1 null genotype and risk of colorectal cancer in Asians as information accumulated by year. Thus, there is an obvious association between the GSTM1 null genotype and risk of colorectal cancer in Asians.
Literatur
1.
Zurück zum Zitat Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, et al. Colorectal cancer. Lancet. 2010;375:1030–47.PubMedCrossRef Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, et al. Colorectal cancer. Lancet. 2010;375:1030–47.PubMedCrossRef
3.
4.
Zurück zum Zitat Peters U, Jiao S, Schumacher FR, Hutter CM, Aragaki AK, Baron JA, et al. Identification of genetic susceptibility loci for colorectal tumors in a genome-wide meta-analysis. Gastroenterology. 2013;144:799–807 e724.PubMedCrossRef Peters U, Jiao S, Schumacher FR, Hutter CM, Aragaki AK, Baron JA, et al. Identification of genetic susceptibility loci for colorectal tumors in a genome-wide meta-analysis. Gastroenterology. 2013;144:799–807 e724.PubMedCrossRef
5.
Zurück zum Zitat Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S-transferase family of enzymes. Mutat Res. 2001;482:21–6.PubMedCrossRef Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S-transferase family of enzymes. Mutat Res. 2001;482:21–6.PubMedCrossRef
6.
Zurück zum Zitat Oakley A. Glutathione transferases: a structural perspective. Drug Metab Rev. 2011;43:138–51.PubMedCrossRef Oakley A. Glutathione transferases: a structural perspective. Drug Metab Rev. 2011;43:138–51.PubMedCrossRef
7.
Zurück zum Zitat Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61:154–66.PubMedCrossRef Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61:154–66.PubMedCrossRef
8.
Zurück zum Zitat Zhang ZJ, Hao K, Shi R, Zhao G, Jiang GX, Song Y, et al. Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: a huge review and meta-analysis. Am J Epidemiol. 2011;173:847–57.PubMedCrossRef Zhang ZJ, Hao K, Shi R, Zhao G, Jiang GX, Song Y, et al. Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: a huge review and meta-analysis. Am J Epidemiol. 2011;173:847–57.PubMedCrossRef
9.
Zurück zum Zitat Taioli E, Flores-Obando RE, Agalliu I, Blanchet P, Bunker CH, Ferrell RE, et al. Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis. 2011;32:1361–5.PubMedCrossRef Taioli E, Flores-Obando RE, Agalliu I, Blanchet P, Bunker CH, Ferrell RE, et al. Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis. 2011;32:1361–5.PubMedCrossRef
10.
Zurück zum Zitat Guo JY, Wan DS, Zeng RP, Zhang Q. The polymorphism of GSTM1, mutagen sensitivity in colon cancer and healthy control. Mutat Res. 1996;372:17–22.PubMedCrossRef Guo JY, Wan DS, Zeng RP, Zhang Q. The polymorphism of GSTM1, mutagen sensitivity in colon cancer and healthy control. Mutat Res. 1996;372:17–22.PubMedCrossRef
11.
Zurück zum Zitat Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A, Kuroki N, et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis. 1996;17:1855–9.PubMedCrossRef Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A, Kuroki N, et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis. 1996;17:1855–9.PubMedCrossRef
12.
Zurück zum Zitat Lee E, Huang Y, Zhao B, Seow-Choen F, Balakrishnan A, Chan SH. Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2. J Toxicol Sci. 1998;23 Suppl 2:140–2.PubMed Lee E, Huang Y, Zhao B, Seow-Choen F, Balakrishnan A, Chan SH. Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2. J Toxicol Sci. 1998;23 Suppl 2:140–2.PubMed
13.
Zurück zum Zitat Saadat I, Saadat M. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett. 2001;169:21–6.PubMedCrossRef Saadat I, Saadat M. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett. 2001;169:21–6.PubMedCrossRef
14.
Zurück zum Zitat Seow A, Yuan JM, Sun CL, Van Den Berg D, Lee HP, Yu MC. Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese health study. Carcinogenesis. 2002;23:2055–61.PubMedCrossRef Seow A, Yuan JM, Sun CL, Van Den Berg D, Lee HP, Yu MC. Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese health study. Carcinogenesis. 2002;23:2055–61.PubMedCrossRef
15.
Zurück zum Zitat Probst-Hensch NM, Sun CL, Van Den Berg D, Ceschi M, Koh WP, Yu MC. The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese health study. Carcinogenesis. 2006;27:2475–82.PubMedCrossRef Probst-Hensch NM, Sun CL, Van Den Berg D, Ceschi M, Koh WP, Yu MC. The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese health study. Carcinogenesis. 2006;27:2475–82.PubMedCrossRef
16.
Zurück zum Zitat Yoshida K, Osawa K, Kasahara M, Miyaishi A, Nakanishi K, Hayamizu S, et al. Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking. Asian Pac J Cancer Prev. 2007;8:438–44.PubMed Yoshida K, Osawa K, Kasahara M, Miyaishi A, Nakanishi K, Hayamizu S, et al. Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking. Asian Pac J Cancer Prev. 2007;8:438–44.PubMed
17.
Zurück zum Zitat Piao JM, Shin MH, Kweon SS, Kim HN, Choi JS, Bae WK, et al. Glutathione-S-transferase (GSTM1, GSTT1) and the risk of gastrointestinal cancer in a Korean population. World J Gastroenterol. 2009;15:5716–21.PubMedCrossRef Piao JM, Shin MH, Kweon SS, Kim HN, Choi JS, Bae WK, et al. Glutathione-S-transferase (GSTM1, GSTT1) and the risk of gastrointestinal cancer in a Korean population. World J Gastroenterol. 2009;15:5716–21.PubMedCrossRef
18.
Zurück zum Zitat Nisa H, Kono S, Yin G, Toyomura K, Nagano J, Mibu R, et al. Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka colorectal cancer study. BMC Cancer. 2010;10:274.PubMedCentralPubMedCrossRef Nisa H, Kono S, Yin G, Toyomura K, Nagano J, Mibu R, et al. Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka colorectal cancer study. BMC Cancer. 2010;10:274.PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Yang G, Gao YT, Shu XO, Cai Q, Li GL, Li HL, et al. Isothiocyanate exposure, glutathione S-transferase polymorphisms, and colorectal cancer risk. Am J Clin Nutr. 2010;91:704–11.PubMedCrossRef Yang G, Gao YT, Shu XO, Cai Q, Li GL, Li HL, et al. Isothiocyanate exposure, glutathione S-transferase polymorphisms, and colorectal cancer risk. Am J Clin Nutr. 2010;91:704–11.PubMedCrossRef
20.
Zurück zum Zitat Yeh CC, Lai CY, Hsieh LL, Tang R, Wu FY, Sung FC. Protein carbonyl levels, glutathione S-transferase polymorphisms and risk of colorectal cancer. Carcinogenesis. 2010;31:228–33.PubMedCrossRef Yeh CC, Lai CY, Hsieh LL, Tang R, Wu FY, Sung FC. Protein carbonyl levels, glutathione S-transferase polymorphisms and risk of colorectal cancer. Carcinogenesis. 2010;31:228–33.PubMedCrossRef
21.
Zurück zum Zitat Koh WP, Nelson HH, Yuan JM, Van den Berg D, Jin A, Wang R, et al. Glutathione S-transferase (GST) gene polymorphisms, cigarette smoking and colorectal cancer risk among Chinese in Singapore. Carcinogenesis. 2011;32:1507–11.PubMedCrossRef Koh WP, Nelson HH, Yuan JM, Van den Berg D, Jin A, Wang R, et al. Glutathione S-transferase (GST) gene polymorphisms, cigarette smoking and colorectal cancer risk among Chinese in Singapore. Carcinogenesis. 2011;32:1507–11.PubMedCrossRef
22.
Zurück zum Zitat Wang J, Jiang J, Zhao Y, Gajalakshmi V, Kuriki K, Suzuki S, et al. Genetic polymorphisms of glutathione S-transferase genes and susceptibility to colorectal cancer: a case–control study in an Indian population. Cancer Epidemiol. 2011;35:66–72.PubMedCrossRef Wang J, Jiang J, Zhao Y, Gajalakshmi V, Kuriki K, Suzuki S, et al. Genetic polymorphisms of glutathione S-transferase genes and susceptibility to colorectal cancer: a case–control study in an Indian population. Cancer Epidemiol. 2011;35:66–72.PubMedCrossRef
23.
Zurück zum Zitat Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCrossRef Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCrossRef
24.
Zurück zum Zitat DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRef DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRef
25.
Zurück zum Zitat Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed
26.
Zurück zum Zitat Zintzaras E, Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol. 2008;61:634–45.PubMedCrossRef Zintzaras E, Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol. 2008;61:634–45.PubMedCrossRef
27.
Zurück zum Zitat Zhu Y, Deng C, Zhang Y, Zhou X, He X. The relationship between GSTM1, GSTT1 gene polymorphisms and susceptibility to sporadic colorectal adenocarcinoma. Zhonghua Nei Ke Za Zhi. 2002;41:538–40.PubMed Zhu Y, Deng C, Zhang Y, Zhou X, He X. The relationship between GSTM1, GSTT1 gene polymorphisms and susceptibility to sporadic colorectal adenocarcinoma. Zhonghua Nei Ke Za Zhi. 2002;41:538–40.PubMed
28.
Zurück zum Zitat Chen K, Jiang QT, Ma XY, Yao KY, Leng SG, Yu WP, et al. Associations between genetic polymorphisms of glutathione S-transferase M1 and T1, smoking and susceptibility to colorectal cancer: a case–control study. Zhonghua Zhong Liu Za Zhi. 2004;26:645–8.PubMed Chen K, Jiang QT, Ma XY, Yao KY, Leng SG, Yu WP, et al. Associations between genetic polymorphisms of glutathione S-transferase M1 and T1, smoking and susceptibility to colorectal cancer: a case–control study. Zhonghua Zhong Liu Za Zhi. 2004;26:645–8.PubMed
29.
Zurück zum Zitat Fan CH, Jin MJ, Zhang Y, Song L, Xu H, Jiang QT, et al. Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer. Zhonghua Yu Fang Yi Xue Za Zhi. 2006;40:13–7.PubMed Fan CH, Jin MJ, Zhang Y, Song L, Xu H, Jiang QT, et al. Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer. Zhonghua Yu Fang Yi Xue Za Zhi. 2006;40:13–7.PubMed
30.
Zurück zum Zitat Aghajany-Nasab M, Panjehpour M, Samiee SM, Rahimi F, Movahedian A. Glutathione S-transferase mu gene variants and colorectal cancer development – use of sequence-specific probes for an Iranian population. Asian Pac J Cancer Prev. 2011;12:1511–5.PubMed Aghajany-Nasab M, Panjehpour M, Samiee SM, Rahimi F, Movahedian A. Glutathione S-transferase mu gene variants and colorectal cancer development – use of sequence-specific probes for an Iranian population. Asian Pac J Cancer Prev. 2011;12:1511–5.PubMed
31.
Zurück zum Zitat Wang B, Huang G, Wang D, Li A, Xu Z, Dong R, et al. Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol. 2010;53:508–18.PubMedCrossRef Wang B, Huang G, Wang D, Li A, Xu Z, Dong R, et al. Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol. 2010;53:508–18.PubMedCrossRef
32.
Zurück zum Zitat Moore LE, Baris DR, Figueroa JD, Garcia-Closas M, Karagas MR, Schwenn MR, et al. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis. 2011;32:182–9.PubMedCrossRef Moore LE, Baris DR, Figueroa JD, Garcia-Closas M, Karagas MR, Schwenn MR, et al. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis. 2011;32:182–9.PubMedCrossRef
33.
Zurück zum Zitat Gong M, Dong W, Shi Z, Xu Y, Ni W, An R. Genetic polymorphisms of GSTM1, GSTT1, and GSTP1 with prostate cancer risk: a meta-analysis of 57 studies. PLoS One. 2012;7:e50587.PubMedCentralPubMedCrossRef Gong M, Dong W, Shi Z, Xu Y, Ni W, An R. Genetic polymorphisms of GSTM1, GSTT1, and GSTP1 with prostate cancer risk: a meta-analysis of 57 studies. PLoS One. 2012;7:e50587.PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Zhang Y, Liu C. The interaction between smoking and GSTM1 variant on lung cancer in the Chinese population. Tumour Biol. 2013;34:395–401.PubMedCrossRef Zhang Y, Liu C. The interaction between smoking and GSTM1 variant on lung cancer in the Chinese population. Tumour Biol. 2013;34:395–401.PubMedCrossRef
35.
Zurück zum Zitat Economopoulos KP, Sergentanis TN. GSTM1, GSTT1, GSTp1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis. Eur J Cancer. 2010;46:1617–31.PubMedCrossRef Economopoulos KP, Sergentanis TN. GSTM1, GSTT1, GSTp1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis. Eur J Cancer. 2010;46:1617–31.PubMedCrossRef
Metadaten
Titel
An updated meta-analysis of the association between GSTM1 polymorphism and colorectal cancer in Asians
verfasst von
Xiang Cai
Lie Yang
Haining Chen
Cun Wang
Publikationsdatum
01.02.2014
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 2/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1125-0

Weitere Artikel der Ausgabe 2/2014

Tumor Biology 2/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.